The 10 th Microbiome Movement Summit Europe brings together leading researchers, clinicians, regulatory specialists, and industry pioneers to drive forward the science and commercialization of ...
The DNA Damage Response (DDR) field is entering a defining new phase. With PARP inhibitors firmly established in the clinic, attention is turning toward next-generation DDR targets – including ATR, ...